Q98439959

Summary

Q98439959 is an interpellation^[1].

Key Facts

• Q98439959 authored Lennart Axelsson^[2].
• Q98439959's instance of is recorded as interpellation^[3].
• Q98439959's part of the series is recorded as interpellations of the 2009/10 legislative session of the Riksdag^[4].
• Q98439959's language of work or name is recorded as Swedish^[5].
• Q98439959 was released on +2010-05-21T00:00:00Z^[6].
• Q98439959's significant event is recorded as debate^[7].
• Q98439959's main subject is medication^[8].
• Q98439959's work available at URL is recorded as http://data.riksdagen.se/dokument/GX10404^[9].
• Q98439959's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GX10404^[10].
• Q98439959's applies to jurisdiction is recorded as Sweden^[11].
• Q98439959's legal citation of this text is recorded as ip. 2009/10:404^[12].
• Q98439959's title is recorded as Försäljning av receptfria läkemedel^[13].
• Q98439959's addressee is recorded as Göran Hägglund^[14].
• Q98439959's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98439959's copyright status is recorded as public domain^[16].

Body

Definition and Type

Q98439959's instance of is recorded as interpellation^[3].